Measles second dose vaccine utilization and associated factors among children aged 24–35 months in Sub-Saharan Africa, a multi-level analysis from recent DHS surveys

Measles second dose vaccine utilization and associated factors among children aged 24–35 months in Sub-Saharan Africa, a multi-level analysis from recent DHS surveys

Abstract Background Although a safe and effective vaccine is available, measles remains an important cause of mortality and morbidity among young children in Sub-Saharan Africa (SSA). The WHO and UNICEF recommended measles-containing vaccine dose 2 (MCV2) in addition to measles-containing vaccine do...

Full description

Bibliographic Details
Main Authors: Dagmawi Chilot, Daniel Gashaneh Belay, Kegnie Shitu, Yibeltal Yismaw Gela, Mihret Getnet, Bezawit Mulat, Atalay Goshu Muluneh, Mehari Woldemariam Merid, Desalegn Anmut Bitew, Adugnaw Zeleke Alem
Format: Article
Language:English
Published: BMC 2022-11-01
Series:BMC Public Health
Subjects:
Measles
Measles-containing vaccine doses 2
MCV2
Immunization
Vaccination
Children
Online Access:https://doi.org/10.1186/s12889-022-14478-x

Internet

https://doi.org/10.1186/s12889-022-14478-x

Similar Items